125 related articles for article (PubMed ID: 38500454)
1. Utility of 30-day mortality as a quality metric for palliative radiation treatment: A population-based analysis from Queensland, Australia.
Guan TL; Kutzko JH; Lunn DP; Dunn NA; Burmeister BH; Dadwal P; Tran N; Holt TR
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):316-324. PubMed ID: 38500454
[TBL] [Abstract][Full Text] [Related]
2. Thirty-day mortality after palliative radiotherapy in advanced cancer patients: Optimizing end-of-life care in Asia.
Kim MS; Cha H; You SH; Kim S
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):307-315. PubMed ID: 38450953
[TBL] [Abstract][Full Text] [Related]
3. Palliative Appropriateness Criteria: A Pragmatic Method to Evaluate the Suitability of Palliative Radiotherapy Fractionation.
Farris JC; Johnson AG; Carriere PP; Patel ZA; Nagatsuka M; Farris MK; Hughes RT
J Palliat Med; 2023 Jan; 26(1):67-72. PubMed ID: 35881861
[No Abstract] [Full Text] [Related]
4. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
5. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
6. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
7. An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada.
Goutam S; Ghosh S; Stosky J; Tam A; Quirk S; Fairchild A; Wu J; Kerba M
Curr Oncol; 2023 Nov; 30(12):10043-10056. PubMed ID: 38132364
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
Mackillop WJ; Kong W
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):51-59. PubMed ID: 26700702
[TBL] [Abstract][Full Text] [Related]
9. Palliative radiotherapy delivery by a dedicated multidisciplinary team facilitates early integration of palliative care: A secondary analysis of routinely collected health data.
Fairchild A; Hill J; Alhumaid M; Rau A; Ghosh S; Le A; Watanabe SM
J Med Imaging Radiat Sci; 2022 Jun; 53(2 Suppl):S51-S55. PubMed ID: 35210177
[TBL] [Abstract][Full Text] [Related]
10. Palliative radiotherapy and the introduction of a Rapid Access Palliative Clinic in a national radiation oncology network.
O'Leary C; Cleary S; Linane H; Hamilton B; Jennings M; Lee Y; Lavan N; O'Reilly M; Twomey M
Ir J Med Sci; 2024 Apr; 193(2):577-583. PubMed ID: 37606800
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.
Angelo K; Norum J; Dalhaug A; Pawinski A; Aandahl G; Haukland E; Engljähringer K; Nieder C
Anticancer Res; 2014 Feb; 34(2):877-85. PubMed ID: 24511026
[TBL] [Abstract][Full Text] [Related]
12. Use of Radiation Therapy Within the Last Year of Life Among Cancer Patients.
Tseng YD; Gouwens NW; Lo SS; Halasz LM; Spady P; Mezheritsky I; Loggers E
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):21-29. PubMed ID: 29487025
[TBL] [Abstract][Full Text] [Related]
13. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study.
Lavergne MR; Johnston GM; Gao J; Dummer TJ; Rheaume DE
Palliat Med; 2011 Mar; 25(2):101-10. PubMed ID: 20937613
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Survival after Palliative Radiotherapy for Malignant Pulmonary Obstruction.
Johnson AG; Soike MH; Farris MK; Hughes RT
J Palliat Med; 2022 Jan; 25(1):46-53. PubMed ID: 34255568
[No Abstract] [Full Text] [Related]
15. A Palliative Radiation Oncology Consult Service Reduces Total Costs During Hospitalization.
Chang S; May P; Goldstein NE; Wisnivesky J; Ricks D; Fuld D; Aldridge M; Rosenzweig K; Morrison RS; Dharmarajan KV
J Pain Symptom Manage; 2018 Jun; 55(6):1452-1458. PubMed ID: 29526611
[TBL] [Abstract][Full Text] [Related]
16. External validation of life expectancy prognostic models in patients evaluated for palliative radiotherapy at the end-of-life.
Mojica-Márquez AE; Rodríguez-López JL; Patel AK; Ling DC; Rajagopalan MS; Beriwal S
Cancer Med; 2020 Aug; 9(16):5781-5787. PubMed ID: 32592315
[TBL] [Abstract][Full Text] [Related]
17. Palliative Radiation Therapy in Bladder Cancer-Importance of Patient Selection: A Retrospective Multicenter Study.
Ali A; Song YP; Mehta S; Mistry H; Conroy R; Coyle C; Logue J; Tran A; Wylie J; Janjua T; Joseph L; Joseph J; Choudhury A
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):389-393. PubMed ID: 31283979
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the use of palliative radiotherapy in Ontario.
Huang J; Zhou S; Groome P; Tyldesley S; Zhang-Solomans J; Mackillop WJ
J Clin Oncol; 2001 Jan; 19(1):137-44. PubMed ID: 11134206
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity on survival after palliative radiotherapy.
Nieder C; Engljähringer K; Angelo K
Strahlenther Onkol; 2014 Nov; 190(12):1149-53. PubMed ID: 25022254
[TBL] [Abstract][Full Text] [Related]
20. Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.
Merchant SJ; Kong W; Mahmud A; Booth CM; Hanna TP
J Palliat Care; 2023 Apr; 38(2):157-166. PubMed ID: 35043749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
